Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events

被引：0
|
作者：
Esmee M. Breddels
Johanna Simin
Romina Fornes
Helene Lilja Engstrand
Lars Engstrand
Robin Bruyndonckx
Nele Brusselaers
机构：
[1] I-BioStat,Centre for Translational Microbiome Research, Department of Microbiology Tumor and Cell Biology
[2] Data Science Institute,Department of Women’s and Children’s Health
[3] Hasselt University,undefined
[4] Karolinska Institutet,undefined
[5] Karolinska University Hospital,undefined
[6] Global Health Institute,undefined
[7] Antwerp University,undefined
来源：
BMC Medicine | / 20卷
关键词：
Proton pump inhibitors; Pregnancy; Maternal and neonatal health; Logistic regression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events
    Breddels, Esmee M.
    Simin, Johanna
    Fornes, Romina
    Engstrand, Helene Lilja
    Engstrand, Lars
    Bruyndonckx, Robin
    Brusselaers, Nele
    [J]. BMC MEDICINE, 2022, 20 (01)
  • [2] Maternal lithium use and the risk of adverse pregnancy and neonatal outcomes: a Swedish population-based cohort study
    Hastie, Roxanne
    Tong, Stephen
    Hiscock, Richard
    Lindquist, Anthea
    Lindstroem, Linda
    Wikstroem, Anna-Karin
    Sundstroem-Poromaa, Inger
    [J]. BMC MEDICINE, 2021, 19 (01)
  • [3] Maternal lithium use and the risk of adverse pregnancy and neonatal outcomes: a Swedish population-based cohort study
    Roxanne Hastie
    Stephen Tong
    Richard Hiscock
    Anthea Lindquist
    Linda Lindström
    Anna-Karin Wikström
    Inger Sundström-Poromaa
    [J]. BMC Medicine, 19
  • [4] Association between proton pump inhibitors use and the risk of maternal infections during pregnancy and postpartum: a Swedish population-based cohort study
    Shabana, H.
    Cesta, C.
    Yan, J.
    Brusselaers, N.
    Rodriguez-Wallberg, K. A.
    [J]. HUMAN REPRODUCTION, 2024, 39
  • [5] Gabapentin use during pregnancy and adverse neonatal birth outcomes: a population-based cohort study
    Lavu, A.
    Peymani, P.
    Alessi-Severini, S.
    Ruth, C.
    Falk, J.
    Kowalec, K.
    Leong, C.
    Derksen, S.
    Ng, M. C.
    Delaney, J.
    Eltonsy, S.
    [J]. EPILEPSIA, 2023, 64 : 21 - 21
  • [6] Gabapentin Use during Pregnancy and Adverse Neonatal Birth Outcomes: A Population-Based Cohort Study
    Lavu, A.
    Peymani, P.
    Severini, S. Alessi
    Ruth, C.
    Falk, J.
    Aboulatta, L.
    Haidar, L.
    Akinola, P. S.
    Farooq, F.
    Kowalec, K.
    Derksen, S.
    Leong, C.
    NG, M.
    Kaul, P.
    Delaney, J.
    Eltonsy, S.
    [J]. BIRTH DEFECTS RESEARCH, 2023, 115 (08): : 873 - 873
  • [7] Gabapentin use during pregnancy and adverse neonatal birth outcomes: A population-based cohort study
    Lavu, Alekhya
    Peymani, Payam
    Alessi-Severini, Silvia
    Ruth, Chelsea
    Falk, Jamison
    Kowalec, Kaarina
    Leong, Christine
    Haidar, Lara
    Aboulatta, Laila
    Akinola, Pelumi Samuel
    Farooq, Faiza
    Derksen, Shelley
    Ng, Marcus C.
    Kaul, Padma
    Delaney, Joseph
    Eltonsy, Sherif
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 520 - 521
  • [8] Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study
    S.-M. Lin
    S.-H. Yang
    C.-C. Liang
    H.-K. Huang
    [J]. Osteoporosis International, 2018, 29 : 153 - 162
  • [9] Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study
    Lin, S. -M.
    Yang, S. -H.
    Liang, C. -C.
    Huang, H. -K.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 (01) : 153 - 162
  • [10] Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study
    Gray, Shelly L.
    Walker, Rod L.
    Dublin, Sascha
    Yu, Onchee
    Bowles, Erin J. Aiello
    Anderson, Melissa L.
    Crane, Paul K.
    Larson, Eric B.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (02) : 247 - 253
12345